S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Price, News & Analysis

$11.55
+0.19 (+1.67%)
(As of 10:58 AM ET)
Today's Range
$11.37
$11.73
50-Day Range
$6.78
$11.36
52-Week Range
$6.37
$15.37
Volume
139,608 shs
Average Volume
1.14 million shs
Market Capitalization
$1.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.10

AdaptHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
6.5% Upside
$12.10 Price Target
Short Interest
Healthy
11.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.73mentions of AdaptHealth in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$2.59 M Sold Last Quarter
Proj. Earnings Growth
27.27%
From $0.88 to $1.12 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.46 out of 5 stars

Medical Sector

566th out of 939 stocks

Home Health Care Services Industry

6th out of 8 stocks

AHCO stock logo

About AdaptHealth Stock (NASDAQ:AHCO)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AHCO Stock Price History

AHCO Stock News Headlines

3 Small-Cap Leaders Poised for Significant Growth
They may not be household names like Meta Platforms Inc. NASDAQ: META or investor favorites like Nvidia Corp. NASDAQ: NVDA, but several small stocks, such as Ultra Clean Holdings, Inc. NASDAQ: UCTT, Powell Industries Inc. NASDAQ: POWL and AdaptHealth Corp. NASDAQ: AHCO are outperforming major indexes.
3 Small-Cap Leaders Poised for Significant Growth (AHCO)
Small stocks like Ultra Clean, Powell and AdaptHealth are outperforming major indexes; small caps have more attractive valuations compared with the S&P 500.
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
ASND Jan 2025 120.000 call
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript
AdaptHealth Corp. (AHCO)
AdaptHealth Corp Gains 28% Despite Increased Loss In Q4
Why AdaptHealth Stock Is Skyrocketing Today
AdaptHealth Q4 2023 Earnings Preview
AHCO Mar 2024 10.000 call
AHCO Mar 2024 12.500 put
In-Depth Examination Of 4 Analyst Recommendations For AdaptHealth
See More Headlines
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.10
High Stock Price Target
$21.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+6.5%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Net Income
$-678,900,000.00
Pretax Margin
-22.62%

Debt

Sales & Book Value

Annual Sales
$3.20 billion
Cash Flow
$10.52 per share
Book Value
$11.06 per share

Miscellaneous

Free Float
114,832,000
Market Cap
$1.51 billion
Optionable
Optionable
Beta
1.01
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives


AHCO Stock Analysis - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price target for 2024?

7 equities research analysts have issued 1-year price targets for AdaptHealth's shares. Their AHCO share price targets range from $6.50 to $21.00. On average, they predict the company's stock price to reach $12.10 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2024?

AdaptHealth's stock was trading at $7.29 on January 1st, 2024. Since then, AHCO stock has increased by 55.8% and is now trading at $11.36.
View the best growth stocks for 2024 here
.

Are investors shorting AdaptHealth?

AdaptHealth saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 8,290,000 shares, a drop of 8.2% from the February 29th total of 9,030,000 shares. Based on an average daily volume of 1,170,000 shares, the short-interest ratio is presently 7.1 days. Currently, 11.8% of the shares of the company are short sold.
View AdaptHealth's Short Interest
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AHCO earnings forecast
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) issued its earnings results on Tuesday, February, 27th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.20 by $0.44. The company had revenue of $858.23 million for the quarter, compared to the consensus estimate of $825.94 million. AdaptHealth had a negative net margin of 21.21% and a positive trailing twelve-month return on equity of 8.84%.

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.3 billion.

What other stocks do shareholders of AdaptHealth own?
Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (6.74%), Vanguard Group Inc. (6.92%), Reinhart Partners LLC. (2.98%), Dimensional Fund Advisors LP (1.22%), Royal Bank of Canada (1.17%) and Palisade Capital Management LP (1.09%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Christopher J Joyce, Daniel Bunting, David Solomon Williams III, Everest Hill Group Inc, Frank Mullen, James E Flynn, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AHCO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners